The NAIP/NLRC4 inflammasome in infection and pathology.


Journal

Molecular aspects of medicine
ISSN: 1872-9452
Titre abrégé: Mol Aspects Med
Pays: England
ID NLM: 7603128

Informations de publication

Date de publication:
12 2020
Historique:
received: 26 02 2020
accepted: 30 04 2020
pubmed: 6 6 2020
medline: 25 9 2021
entrez: 6 6 2020
Statut: ppublish

Résumé

In this review we give an overview of the NAIP/NLRC4 activation mechanism as well as the described roles of this inflammasome, with a focus on in vivo infection and pathology. After ligand recognition by NAIP sensor proteins the NAIP/NLRC4 inflammasome forms through oligomerization with the NLRC4 adaptor to activate Caspase-1. The activating ligands are intracellular bacterial flagellin or type-3 secretion system components, delivered by pathogens. In vivo experiments indicate a role in macrophages during lung, spleen and liver infection and systemic sepsis like conditions, as well as in intestinal epithelial cells. Upon NAIP/NLRC4 activation in the intestine, epithelial cell extrusion is triggered in addition to the canonical inflammasome outcomes of cytokine cleavage and pyroptosis. Human patients with auto-activating mutations in NLRC4 present with an autoinflammatory syndrome including enterocolitis. Although one of the better understood inflammasomes in terms of mechanism, tissue specific functions of NAIP/NLRC4 are only beginning to be understood.

Identifiants

pubmed: 32499055
pii: S0098-2997(20)30024-8
doi: 10.1016/j.mam.2020.100863
pii:
doi:

Substances chimiques

CARD Signaling Adaptor Proteins 0
Calcium-Binding Proteins 0
Inflammasomes 0
NAIP protein, human 0
NLRC4 protein, human 0
Neuronal Apoptosis-Inhibitory Protein 0
Flagellin 12777-81-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100863

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Renate Bauer (R)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA; Department of Biosciences, University of Salzburg, A-5020, Salzburg, Austria.

Isabella Rauch (I)

Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. Electronic address: rauchi@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH